Biologistika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 64,850 | 73,516 | 65,468 | 69,329 | 87,185 | 97,215 | 112,867 | 134,404 |
| Profit before tax | 12,400 | 18,456 | 18,100 | 1 | 8,973 | 21,346 | 21,233 | 12,838 |
| Net profit | 11,780 | 15,688 | 15,760 | -5 | 8,516 | 20,314 | 20,215 | 12,068 |
| Equity | 27,474 | 43,162 | 58,921 | 62,321 | 70,837 | 79,151 | 87,367 | 87,435 |
| Liabilities | 3,995 | 5,598 | 5,041 | 2,809 | 4,369 | 5,707 | 5,889 | 39,976 |
| Non-current assets | 21,457 | 18,446 | 15,847 | 43,651 | 44,069 | 48,502 | 59,089 | 97,307 |
| Current assets | 9,973 | 30,218 | 48,059 | 20,989 | 30,607 | 35,696 | 33,494 | 28,889 |
| Total assets | 31,430 | 48,664 | 63,906 | 64,640 | 74,676 | 84,198 | 92,583 | 126,196 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 28,127 | 32,436 | 37,739 |
| Social insurance contributions | - | - | - | - | - | 12,180 | 1,625 | 17,839 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +17.4% | +13.4% | -10.9% | +5.9% | +25.8% | +11.5% | +16.1% | +19.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 37.5% | 32.2% | 24.7% | 0.0% | 11.4% | 24.1% | 21.8% | 9.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 42.9% | 36.3% | 26.7% | 0.0% | 12.0% | 25.7% | 23.1% | 13.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 18.2% | 21.3% | 24.1% | 0.0% | 9.8% | 20.9% | 17.9% | 9.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 19.1% | 25.1% | 27.6% | 0.0% | 10.3% | 22.0% | 18.8% | 9.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 13,190 | 16,965 | 16,367 | 17,332 | 21,796 | 24,821 | 36,606 | 34,316 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biologistika - Social security debts
The company had no debts to Sodra
Biologistika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-05-13 | 2025-05-13 | 0.27 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biologistika, UAB (code 304239940) is a Private Limited Liability Company engaged in logistics service activities. In 2025, the company generated revenue of EUR 134.4K, up 19.1% year on year and 38.2% over two years. Net profit declined to EUR 12.1K from EUR 20.2K in 2024 and EUR 20.3K in 2023, while the net profit margin fell to 9.0% from 17.9% in 2024 and 20.9% in 2023. Profit before tax also decreased to EUR 12.8K in 2025. The company’s balance sheet expanded, with total assets rising to EUR 126.2K from EUR 92.6K in 2024 and EUR 84.2K in 2023. Equity remained stable at EUR 87.4K, while liabilities increased to EUR 40.0K from EUR 5.9K a year earlier. Long-term assets grew to EUR 97.3K, while short-term assets declined to EUR 28.9K. The equity ratio stood at 69.3%, debt-to-equity at 0.46, asset turnover at 1.07x, ROE at 13.8%, and ROA at 9.6%. Revenue per employee was EUR 44.8K in 2025.